FN1 and pancreatic adenocarcinoma: Yu et al indicated that GBP2 could enhance the glioblastoma invasion through Stat3/fibronectin pathway.39 In pancreatic adenocarcinoma (PAAD), GBP2 expression was significantly upregulated in PAAD tissues.